With box warnings

Without box warnings

Branded

Generic

4 results

kisqali
(ribociclib)
Novartis Pharmaceuticals Corporation
Usage: KISQALI is indicated for adjuvant treatment of adults with HR-positive, HER2-negative early breast cancer at high risk of recurrence, and for adults with advanced or metastatic HR-positive, HER2-negative breast cancer, in combination with aromatase inhibitors or fulvestrant.
letrozole
(Letrozole)
Chartwell RX, LLC
Usage: Letrozole Tablets are indicated for the adjuvant and extended adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer, as well as for first and second-line treatment of locally advanced or metastatic breast cancer in postmenopausal women.
letrozole
(Letrozole Tablets)
Yiling Pharmaceutical, Inc.
Usage: Letrozole is indicated for the adjuvant treatment of hormone receptor-positive early breast cancer in postmenopausal women, as well as for extended adjuvant therapy following tamoxifen. It is also used as a first and second-line treatment for advanced, locally advanced, or metastatic breast cancer in postmenopausal women.
verzenio
(abemaciclib)
Eli Lilly and Company
Usage: VERZENIO (abemaciclib) is indicated for adults with HR-positive, HER2-negative breast cancer. It is used in combination with endocrine therapy for early breast cancer at high risk of recurrence and for advanced or metastatic cases, either with an aromatase inhibitor, fulvestrant, or as monotherapy after prior treatments.

Medications for Advanced Breast Cancer

kisqali